Adenoviral E1a expression levels affect virus-selective replication in human cancer cells

Area of Science:

• Oncolytic virotherapy
• Adenovirus gene regulation
• Cancer cell biology

Background:

• Oncolytic adenoviruses target cancer cells by replicating within them.
• Controlling viral gene expression, like E1a, using tumor-specific promoters is a promising strategy.
• Potential for viral replication in normal cells necessitates careful E1a expression control.

Purpose of the Study:

• To investigate the impact of E1a expression levels on oncolytic adenovirus replication in human cells.
• To evaluate the efficacy of different promoters (endogenous, CMV, none) in controlling E1a expression and subsequent viral replication.
• To understand the role of cellular factors in E1a-mediated viral replication.

Main Methods:

• Construction of three E1B55K-mutated adenovirus vectors with varying E1a gene control: no promoter, endogenous promoter, and CMV promoter.
• Assessment of E1a expression levels and virus replication titers in various human cancer and normal cell lines.
• Comparative analysis of viral replication between engineered vectors and wild-type virus.

Main Results:

• High E1A expression driven by the CMV promoter enhanced E1B55K-mutated virus replication in some cancer cells, exceeding wild-type titers.
• CMV promoter did not consistently enhance replication in all tested cancer cells (e.g., OE33, OsACL), indicating dependence on cellular factors.
• Adenovirus lacking a specific promoter still exhibited leaky E1A expression, leading to replication in both normal and cancer cells.

Conclusions:

• Increased E1A levels can enhance oncolytic adenovirus replication, but this effect is cell-dependent.
• Leaky E1A expression from non-promoter-controlled vectors poses a risk for viral replication in normal tissues.
• Future oncolytic adenovirus development must prioritize complete E1a silencing in normal cells to improve safety and specificity.